Claudio Hidalgo Cantabrana

Company: Microviable Therapeutics
Job title: CEO
Seminars:
MVT-201 as an Adjuvant to Anti-PD1 in Melanoma 11:00 am
day: Conference Day One, Track Two, AM
Company: Microviable Therapeutics
Job title: CEO
day: Conference Day One, Track Two, AM